Wine for Life
An evening of fine wines and delectables
Friday, OCT. 18, 2024
5:45-7 p.m. VIP Tasting ~ 7-10 p.m. Tasting and Wine “Pull”
An evening of fine wines and delectables
Friday, OCT. 18, 2024
5:45-7 p.m. VIP Tasting ~ 7-10 p.m. Tasting and Wine “Pull”
The JEDI Rare Cancer Foundation has committed to raise $5 Million over 5 years to support CURE: The Rare Cancer Initiative. Utilizing groundbreaking single-cell science and analysis, this transformative research leverages the institutional experience and resources present at Cleveland’s Case Comprehensive Cancer Center through a collaborative national effort that will accelerate discovery to defeat rare cancer as we know it and save lives around the world.
Rare cancer comprises approximately 25% of cancers diagnosed annually, yet rare cancer patients and their families have little or no hope of positive outcomes. What is tragically obvious to rare cancer researchers, medical scientists, hospitals, and doctors is widely unknown until a loved one is diagnosed with a rare cancer.
On April 26, 2022, Columbia University Irving Medical Center and the JEDI Rare Cancer Foundation co-sponsored “Rare Cancers: Unmet Medical Needs.” The conference brought needed attention to the scarce resources and treatment options available to the more than 400,000 Americans diagnosed with a rare cancer each year – and to the major advancements in medical science, emphasizing suggested outcomes that can accelerate discovery and move rare cancer progress forward.
Since 2022, the foundation’s JEDIs for Survival teams and generous donors have supported Cycle for Survival’s annual fundraiser. We ride to accelerate progress in rare cancer research and lifesaving clinical trials led by Memorial Sloan Kettering Cancer Center (MSK), bringing new and better treatments to people around the world.
Your generous donation is an investment in ending rare cancer as we know it.
We accelerate discovery
Comment, Like, Share & Follow Us on Social Media.
Together, we can take action against rare cancer and help save lives.
The Jed Ian Taxel Foundation for Rare Cancer Research | P.O. Box 683501 Park City, Utah 84068
The Jed Ian Taxel Foundation for Rare Cancer Research, Inc. is a 501 (C)(3) Non-Profit Organization, accepting Tax Deductible donations from individuals, corporations, family-advised funds and foundations. Federal Tax ID 86-2610819
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.